Endometriosis is a chronic condition where tissue resembling the endometrium (inner lining of the uterus) grows outside the uterus. These growths:
About 50% of the risk appears due to genetic factors, based on twin studies.
Understanding genetics helps researchers:
Researchers used restriction fragment length polymorphisms (RFLPs) to map big-effect mutations in monogenic diseases (e.g., cystic fibrosis). But endometriosis isn't monogenic — it involves many small-effect variants.
Key innovation: Use genotyping chips with ~800,000 SNPs spread across the entire genome.
A significant SNP is usually not the causal variant — it’s a “tag” for a region. Causal fine-mapping is needed to find the true functional variant.
Two key twin studies (1999 and later replication) showed:
Higher concordance in MZ → ~51% heritability.
This finding justified building large international genetic consortia.
Growth of sample size over the years led to dramatic increases in discoveries.
Most recent study:
Most GWAS variants lie in non-coding regions:
These influences typically modify gene expression, not protein sequence.
Gene expression is controlled by:
Projects like ENCODE and NIH Roadmap map these, but tissue coverage is incomplete.
An expression quantitative trait locus (eQTL) is a genetic variant affecting gene expression.
Researchers combine:
To test whether the same variant explains both.
Statistical colocalization helps choose between these models.
A SNP lies in a bi-directional promoter, altering both neighboring genes. Both genes have plausible biological roles in endometriosis.
Not only expression changes matter—variants can alter:
Many disease associations may actually be mediated through splicing, not expression.
Key limitations:
GWAS variants may only act in:
Bulk tissue hides these nuances.
When combining all likely causal genes, patterns appear:
Small genetic effects can accumulate → meaningful biological impact.
Endometriosis shares genetic components with:
This has clinical implications:
Endometriosis is a common, chronic, genetically influenced disease where endometrium-like tissue grows outside the uterus. Modern genetics—especially GWAS—has identified dozens of risk regions, but linking them to true causal genes is hard because most variants regulate expression rather than protein structure, and these regulatory effects are subtle, tissue-specific, and cycle-dependent. By integrating GWAS with eQTL, splicing, methylation, and cell-type-specific data, researchers are beginning to map the regulatory pathways involved, revealing roles in reproductive development, epithelial regulation, proliferation, and inflammation. Although significant progress has been made, full biological understanding and translation to clinical solutions remain major challenges.